Home ClostraBio

ClostraBio

In operation
Seed Round Financing
Startups Developing Drugs
Basic
Enterprise Profile

Basic Information

ClostraBio, a startup developing drugs that can prevent allergic reactions to food. ClostraBio's scientific team has made significant discoveries highlighting the importance of gut microbiota in modulating food allergy sensitization. The company is committed to gaining a deeper understanding of the role gut microbes play in intestinal barrier function and identifying mechanisms of barrier protection.
ClostraBio
United States of America
less than 15 people
January 01, 2016
information@clostrabio.com

Enterprise Profile

Industrial Sector
Pharmaceuticals and Biological Products New Drug Development Manufacture of Chemical Pharmaceutical Preparations